Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.

Gupta R, Li W, Yan XJ, Barrientos J, Kolitz JE, Allen SL, Rai K, Chiorazzi N, Mongini PKA.

J Immunol. 2019 May 15;202(10):2924-2944. doi: 10.4049/jimmunol.1801142. Epub 2019 Apr 15.

PMID:
30988120
2.

Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.

Gupta R, Yan XJ, Barrientos J, Kolitz JE, Allen SL, Rai K, Chiorazzi N, Mongini PKA.

J Immunol. 2018 Sep 1;201(5):1570-1585. doi: 10.4049/jimmunol.1800591. Epub 2018 Aug 1.

PMID:
30068596
3.

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Mongini PK, Gupta R, Boyle E, Nieto J, Lee H, Stein J, Bandovic J, Stankovic T, Barrientos J, Kolitz JE, Allen SL, Rai K, Chu CC, Chiorazzi N.

J Immunol. 2015 Aug 1;195(3):901-23. doi: 10.4049/jimmunol.1403189. Epub 2015 Jul 1.

4.

Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.

Mongini PK, Kramer JM, Ishikawa TO, Herschman H, Esposito D.

Clin Immunol. 2014 Jul;153(1):79-90. doi: 10.1016/j.clim.2014.03.012. Epub 2014 Mar 29.

5.

Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Haque S, Yan XJ, Rosen L, McCormick S, Chiorazzi N, Mongini PK.

FASEB J. 2014 Feb;28(2):627-43. doi: 10.1096/fj.13-237792. Epub 2013 Oct 21.

6.

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.

Patten PE, Chu CC, Albesiano E, Damle RN, Yan XJ, Kim D, Zhang L, Magli AR, Barrientos J, Kolitz JE, Allen SL, Rai KR, Roa S, Mongini PK, MacCarthy T, Scharff MD, Chiorazzi N.

Blood. 2012 Dec 6;120(24):4802-11. doi: 10.1182/blood-2012-08-449744. Epub 2012 Oct 15.

7.

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

Damle RN, Temburni S, Banapour T, Paul S, Mongini PK, Allen SL, Kolitz JE, Rai KR, Chiorazzi N.

Blood. 2012 Sep 20;120(12):2438-49. Epub 2012 Aug 8.

8.

A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Lee H, Haque S, Nieto J, Trott J, Inman JK, McCormick S, Chiorazzi N, Mongini PK.

J Immunol. 2012 Jun 15;188(12):6093-108. doi: 10.4049/jimmunol.1103037. Epub 2012 May 18.

9.

A cyclooxygenase-2/prostaglandin E2 pathway augments activation-induced cytosine deaminase expression within replicating human B cells.

Lee H, Trott JS, Haque S, McCormick S, Chiorazzi N, Mongini PK.

J Immunol. 2010 Nov 1;185(9):5300-14. doi: 10.4049/jimmunol.1000574. Epub 2010 Oct 4.

10.

Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor.

Ghumra A, Shi J, Mcintosh RS, Rasmussen IB, Braathen R, Johansen FE, Sandlie I, Mongini PK, Areschoug T, Lindahl G, Lewis MJ, Woof JM, Pleass RJ.

Eur J Immunol. 2009 Apr;39(4):1147-56. doi: 10.1002/eji.200839184.

11.

Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Ghumra A, Semblat JP, McIntosh RS, Raza A, Rasmussen IB, Braathen R, Johansen FE, Sandlie I, Mongini PK, Rowe JA, Pleass RJ.

J Immunol. 2008 Aug 1;181(3):1988-2000.

12.

COX-2 expression in B lymphocytes: links to vaccines, inflammation and malignancy.

Mongini PK.

Clin Immunol. 2007 Nov;125(2):117-9. Epub 2007 Sep 14. No abstract available.

PMID:
17869184
13.

APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.

Mongini PK, Inman JK, Han H, Fattah RJ, Abramson SB, Attur M.

J Immunol. 2006 Jun 1;176(11):6736-51.

14.

Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation.

Mongini PK, Inman JK, Han H, Kalled SL, Fattah RJ, McCormick S.

J Immunol. 2005 Nov 1;175(9):6143-54.

15.

Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.

Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK.

J Immunol. 2003 Nov 15;171(10):5244-54.

16.
18.

Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma.

Mongini PK, Liu Q, Vilensky MA, Highet PF, Inman JK.

Blood. 1998 Nov 15;92(10):3756-71.

19.
20.

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

Rudich SM, Mongini PK, Perez RV, Katznelson S.

Transplant Proc. 1998 Jun;30(4):992-5. No abstract available.

PMID:
9636401
21.
22.

Biological function and distribution of human interleukin-12 receptor beta chain.

Wu CY, Warrier RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PK, Stern AS, Gubler U, Presky DH, Gately MK.

Eur J Immunol. 1996 Feb;26(2):345-50.

PMID:
8617302
24.

A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.

Mongini PK, Blessinger CA, Chiorazzi N, Rajaram N, Rudich SM.

Int Immunol. 1995 Feb;7(2):317-30.

PMID:
7734425
26.

IL-12 receptor. II. Distribution and regulation of receptor expression.

Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK.

J Immunol. 1992 May 15;148(10):3125-32.

PMID:
1578139
27.

Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM.

Mongini PK, Blessinger CA, Dalton JP, Seki T.

Cell Immunol. 1992 Apr;140(2):478-94.

PMID:
1371950
28.
29.

Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.

Mongini PK, Blessinger C, Posnett DN, Rudich SM.

J Immunol. 1989 Sep 1;143(5):1565-74.

PMID:
2788188
30.

Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Mongini PK, Rudich SM.

Springer Semin Immunopathol. 1989;11(2):93-122. Review. No abstract available.

PMID:
2683163
31.
32.
33.

Culture-well solid-phase 3H-RIA for the isotype-specific measurement of antibody from mouse and human antibody-secreting cells.

Mongini PK, Blessinger C.

Methods Enzymol. 1986;121:438-53. No abstract available.

PMID:
3724483
34.
36.
37.

Immune response to a thymus-dependent form of B512 dextran requires the presence of Lyb-5+ lymphocytes.

Stein KE, Zopf DA, Miller CB, Johnson BM, Mongini PK, Ahmed A, Paul WE.

J Exp Med. 1983 Feb 1;157(2):657-66.

41.

Role of the thymus in directing the development of a subset of B lymphocytes.

Mond JJ, Scher I, Cossman J, Kessler S, Mongini PK, Hansen C, Finkelman FD, Paul WE.

J Exp Med. 1982 Mar 1;155(3):924-36.

43.
44.

Role of T lymphocytes in the response to TNP-AECM-Ficoll.

Mond JJ, Mongini PK, Sieckmann D, Paul WE.

J Immunol. 1980 Sep;125(3):1066-70.

PMID:
6774013
46.

Lactic dehydrogenase virus alteration of lymphocyte circulation.

Mongini PK, Rosenberg LT.

J Immunol. 1978 Feb;120(2):459-62.

PMID:
621389
48.

Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice.

Mongini PK, Rosenberg LT.

J Immunol. 1975 Feb;114(2 Pt 1):650-4.

PMID:
1120902

Supplemental Content

Loading ...
Support Center